Abstract: The present disclosure relates to an apparatus and method for identifying light source. The method includes receiving an infrared image of an environment captured by an imaging apparatus in a first configuration. The method also includes identifying, based on the infrared image, that a light source exists in the environment captured in the infrared image. The method further includes generating an order for changing the imaging apparatus from the first configuration to a second configuration.

Abstract: The present disclosure describes novel IDO inhibitors and methods for preparing them. The pharmaceutical compositions comprising such IDO inhibitors and methods of using them for treating cancer, infectious diseases, and other disorders are also described.

Abstract: A door assembly for an air conditioner indoor unit includes a door mounting plate, including a receiving chamber having a fitting opening on one side and a bottom wall on another side, a door arranged adjacent to the bottom wall of the receiving chamber and configured to be movable toward and away from the door mounting plate, and a plurality of driving assemblies arranged in the receiving chamber. An end of each driving assembly passes through the bottom wall of the receiving chamber to be connected to the door. Locations of the ends of the plurality of driving assemblies connected to the door are uniformly distributed on the door. The plurality of driving assemblies are configured to drive the door to move.

Abstract: A door assembly for an air conditioner indoor unit includes a door mounting plate, a door, a guiding part, and a drive assembly. The door mounting plate includes a receiving groove and a guiding groove. The door is configured to be movable in a direction approaching and away from the door mounting plate. The guiding part is connected with the door, located at a side of the door facing the door mounting plate, and movably disposed in the guiding groove. The drive assembly is configured to drive the door to move, and is disposed in the receiving groove.

Abstract: The present disclosure describes novel TRK kinase inhibitors and methods for preparing them. The pharmaceutical compositions comprising such TRK kinase inhibitors and methods of using them for treating cancer, infectious diseases, and other disorders are also described.

Abstract: A process for dehydrating methanol to dimethyl ether product in the presence of an aluminosilicate zeolite catalyst and a promoter selected from (i) aldehyde of formula R1CHO (Formula I) in which R1 is hydrogen, a C1-C11 alkyl group or a C3-C11 alkyl group in which 3 or more carbon atoms are joined to form a ring; or (ii) acetal derivative of an aldehyde of Formula I; and the molar ratio of promoter to methanol is maintained at 0.1 or less.

Abstract: Insulin dimers conjugated to peptides having at least one incretin activity are disclosed.

Abstract: A process for dehydrating methanol to dimethyl ether using a Brønsted acid catalyst which is a 1-dimensional or a 3-dimensional aluminosilicate zeolite or a heteropolyacid, and a promoter of Formula I CnH(2n+1)CO2CH3 wherein n=1 to 11 or Formula II CmH2m(CO2CH3)2 wherein m=2 to 7 and the molar ratio of promoter to methanol is maintained at less than 1.

Abstract: The present disclosure describes carbamate and urea compounds as novel multikinase inhibitors and methods for preparing them. The pharmaceutical compositions comprising such multikinase inhibitors and methods of using them for treating cancer, infectious diseases, and other disorders associated with kinases are also described.

Abstract: The present disclosure relates to devices and methods for detecting and removing vapor for an imaging acquisition device. A device for detecting and removing vapor may include a first light guide. The first light guide may include a first end to receive a light beam, and a second end to output the light beam at a predetermined angle with respect to a reference plane, so that when the light beam enters a target light transmission media from the first light guide, the light beam substantially perfectly reflects between a first surface and a second surface of the target light transmission media. The first surface and second surface may substantially parallel to the reference plane.

Abstract: Provided are methods for treating or preventing a fibrotic disease selected from systemic sclerosis, cystic fibrosis, non-alcoholic steatohepatitis, Peyronie's disease, or interstitial lung disease; the method comprising administering a therapeutically effective amount of a compound of Formula (I) (wherein R1, R2, R3, R4, and R5 are as herein described) or a pharmaceutically acceptable salt thereof, to a patient in need of such therapy.

Abstract: The present disclosure relates to devices and methods for detecting and removing vapor for an imaging acquisition device. A device for detecting and removing vapor may include a first light guide. The first light guide may include a first end to receive a light beam, and a second end to output the light beam at a predetermined angle with respect to a reference plane, so that when the light beam enters a target light transmission media from the first light guide, the light beam substantially perfectly reflects between a first surface and a second surface of the target light transmission media. The first surface and second surface may substantially parallel to the reference plane.

Abstract: The present disclosure describes novel TRK kinase inhibitors and methods for preparing them. The pharmaceutical compositions comprising such TRK kinase inhibitors and methods of using them for treating cancer, infectious diseases, and other disorders are also described.

Abstract: The present disclosure describes novel PRMT5 inhibitors and methods for preparing them. The pharmaceutical compositions comprising such PRMTS inhibitors and methods of using them for treating cancer, infectious diseases, and other PRMTS associated disorders are also described.

Abstract: The present disclosure relates to an apparatus and method for identifying light source. The method includes receiving an infrared image of an environment captured by an imaging apparatus in a first configuration. The method also includes identifying, based on the infrared image, that a light source exists in the environment captured in the infrared image. The method further includes generating an order for changing the imaging apparatus from the first configuration to a second configuration.

Abstract: Provided are a method and a system for controlling wind turbine shutdown. The method includes: obtaining, according to a preset sampling period, a grid voltage for a wind turbine, and sending the obtained grid voltage to an converter controller; determining, by the converter controller and based on the grid voltage, an operating condition of a power grid is power outage of power grid; sending, in a case that the power outage of power grid is determined, a signal indicating power outage of power grid to a main controller of a main control system of the wind turbine; and controlling, by the main controller in a case that the signal indicating power outage of power grid is received, a pitch system to perform a variable-rate feathering.

Abstract: The invention provides certain fused pyrazine compounds of the Formula (I) or a pharmaceutically acceptable salts thereof, wherein X, Y, R1, R3, R4a, R5a, R5b, R6, and the subscript t are as described herein. The compounds or their pharmaceutically acceptable salts can modulate the body's production of cyclic guanosine monophosphate (“cGMP”), and are generally suitable for the therapy and prophylaxis of diseases or disorders which are associated with a disturbed cGMP balance. The invention also provides pharmaceutical compositions which comprise compounds of Formula (I) or pharmaceutically acceptable salts thereof. The invention also relates to methods for use of the compounds or their pharmaceutically acceptable salts in the therapy and prophylaxis of the abovementioned diseases and disorders and for preparing pharmaceuticals for this purpose.

Abstract: A process for dehydrating methanol to dimethyl ether product in the presence of an aluminosilicate zeolite catalyst and a promoter selected from (i) aldehyde of formula R1CHO (Formula I) in which R1 is hydrogen, a C1-C11 alkyl group or a C3-C11 alkyl group in which 3 or more carbon atoms are joined to form a ring; or (ii) acetal derivative of an aldehyde of Formula I; and the molar ratio of promoter to methanol is maintained at 0.1 or less.

Abstract: The present disclosure describes novel IDO inhibitors and methods for preparing them.

Abstract: An air duct having first to third air ducts, each of the first to third air ducts has a duct structure having a first end and a second end, the duct structure of the each of the first to third air ducts are separable from each other, a cross sectional area of the first end is greater than a cross sectional area of the second end, a plurality of cross sectional areas between the first end and the second end decrease progressively from the first end to the second end, and the first to third air ducts are communicated successively in a direction such that the second end of the duct structure of the third air duct is arranged closer to the second end of the duct structure of the first air duct and further from the first end of the duct structure of the first air duct.